The Toronto-Dominion Bank 13D and 13G filings for UroGen Pharma Ltd.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-15 1:46 pm Purchase | 2026-03-31 | 13G | UROGEN PHARMA LTD URGN | The Toronto-Dominion Bank | 2,616,714 5.400% | 314,380 (+13.65%) | Filing |
| 2026-02-13 1:04 pm Sale | 2025-12-31 | 13G | UROGEN PHARMA LTD URGN | The Toronto-Dominion Bank | 2,302,334 4.900% | -888,176 (-27.84%) | Filing |
| 2025-11-14 11:26 am Purchase | 2025-09-30 | 13G | UROGEN PHARMA LTD URGN | The Toronto-Dominion Bank | 3,190,510 6.900% | 3,190,510 (New Position) | Filing |